Delivery Order SPE2DB22D2206-SPE2DB25FHR14
Award Date
6/27/25
Potential Completion Date
6/30/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $1,339.51 firm-fixed-price delivery order for the supply of DALIRESP 500 MCG TABLET 90S. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,331.62 firm fixed-price contract is for the delivery of DALIRESP 500 MCG TABLET 90S. It has an ultimate completion date of June 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $22,588.26 firm fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a prescription medication. The contract has an ultimate completion date of June 23, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,989.26 and a period of performance through June 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,476.34, is for the delivery of DALIRESP 500 MCG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a completion date of May 3, 2023 and a ceiling value of $1,938.16. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,082.72 firm fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has a performance period through June 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,044.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract has a period of performance through April 17, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,232.46, is for the delivery of DALIRESP 250 MCG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DALIRESP 500 MCG TABLET 90S. The contract, which has a ceiling value of $3,403.09, was awarded on June 10, 2025 with a completion date of June 11, 2025. The contract is being funded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...